GlassScriptPhysician profile
Nathaniel Whitney
NPI 1730356346
$14,282.78
in general payments reported to CMS, 2019-2025
7 companies · $8,152 in 2025
The $8,152 reported for 2025 was more than what 84% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,191 · 2020: $33.69 · 2021: $1,037 · 2022: $2,384 · 2023: $378 · 2024: $108 · 2025: $8,152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,938 · Travel and Lodging: $949 · Food and Beverage: $751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,937.50 |
| Travel and Lodging | $948.99 |
| Food and Beverage | $750.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $7,979.68 | 2025 | Prospera |
| Globus Medical, INC. | $5,890.60 | 2019-2025 | Excelsiusgps Robotic Navigation System, Excelsius3d Imaging System, Xlif |
| Medtronic USA, INC. | $119.70 | 2019 | |
| Abbott Laboratories | $119.37 | 2023-2025 | Eterna |
| Medtronic, INC. | $82.75 | 2022 | |
| Biotronik INC. | $56.99 | 2025 | Prospera |
| Depuy Synthes Sales INC. | $33.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Whitney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.